In Depth 14 Apr 2025
Metabolomics: The study of biology’s dark matter
Learn about metabolomics, biology’s fourth language that has remained vastly untapped up until now and could accelerate biotech research.
About
After I graduated with a master’s degree in European Law from the
University of Tours, I decided to study journalism at the All Media
Journalism Institute of Lille. During this time, I discovered the healthcare
innovation ecosystem and enjoyed writing about it for Eurasanté, a French
healthcare cluster. I am interested in different subjects other than
healthcare and biotechnology: cinema, sports, photography… Journalism
had always been at the back of my mind, and I am delighted to write for
Labiotech as a junior reporter. When I am not working you might find me on the tennis court or picking up the next piece of furniture I will renovate.
Articles by Jules Adam
News and Trends 9 Apr 2025
The biotech job market in 2025: Still in survival mode?
The biotech job market has been tough the last few years but is it getting better? Delve into the industry’s job market in 2025.
News and Trends 4 Apr 2025
Developing drugs from outer space: Exobiosphere raises €2 million
Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round.
In Depth 2 Apr 2025
Beyond amyloid: The search for the next big thing in Alzheimer’s treatment
Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments.
In Depth 26 Mar 2025
A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations
Delve into the kinase inhibitors’ diverse landscape, from cancer breakthroughs to autoimmune disease innovations.
News and Trends 25 Mar 2025
AbbVie and Genmab: Can a legal battle break a billion-dollar bond?
As AbbVie accuses Genmab of unlawfully using proprietary ADC technology, find out about their collaboration and the dispute opposing them.
ADVERTISEMENT
ADVERTISEMENT
Interview 20 Mar 2025
AI meets biotech: Bullfrog AI’s CEO on the TechBio boom
Find out about how TechBios are changing the industry by leveraging AI and partnering with biotech in our interview with Bullfrog AI’s CEO.
In Depth 11 Mar 2025
The gender gap in clinical trials: Why women are still underrepresented
Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is correcting it.
Best in Biotech 5 Mar 2025
Seven biotech companies keeping Taiwan dynamic in 2025
Discover 7 biotech companies in Taiwan, a rising regional player in precision medicine, immunotherapy, and drug development, backed by strong research and government support.
In Depth 17 Feb 2025
Biotech’s legal storm: Why securities class action lawsuits are surging
Find out about what’s behind the increase of securities class action lawsuits in the biotech industry and how to prevent them.
Best in Biotech 13 Feb 2025
Seven companies using metabolomics to decode biology
Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.
News and Trends 13 Feb 2025
DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup
Find out about a new AI-driven company that emerges from stealth today to create novel protein – Latent Labs.
ADVERTISEMENT
